It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AIMD’s FA Score shows that 0 FA rating(s) are green whileGCTK’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AIMD’s TA Score shows that 4 TA indicator(s) are bullish while GCTK’s TA Score has 1 bullish TA indicator(s).
AIMD (@Medical/Nursing Services) experienced а +29.27% price change this week, while GCTK (@Pharmaceuticals: Other) price change was -6.58% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.03%. For the same industry, the average monthly price growth was +0.41%, and the average quarterly price growth was +3.73%.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.26%. For the same industry, the average monthly price growth was -2.99%, and the average quarterly price growth was +3.27%.
The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
@Pharmaceuticals: Other (+2.26% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
AIMD | GCTK | AIMD / GCTK | |
Capitalization | 13.3M | 3.3M | 403% |
EBITDA | N/A | N/A | - |
Gain YTD | 39.474 | -98.700 | -40% |
P/E Ratio | N/A | N/A | - |
Revenue | N/A | N/A | - |
Total Cash | 2.63M | 1M | 262% |
Total Debt | 12M | 262K | 4,580% |
AIMD | GCTK | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 97 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 65 Fair valued | 96 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 98 | 100 | |
PRICE GROWTH RATING 1..100 | 48 | 65 | |
P/E GROWTH RATING 1..100 | 100 | 100 | |
SEASONALITY SCORE 1..100 | 85 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
AIMD's Valuation (65) in the null industry is in the same range as GCTK (96). This means that AIMD’s stock grew similarly to GCTK’s over the last 12 months.
AIMD's Profit vs Risk Rating (100) in the null industry is in the same range as GCTK (100). This means that AIMD’s stock grew similarly to GCTK’s over the last 12 months.
AIMD's SMR Rating (98) in the null industry is in the same range as GCTK (100). This means that AIMD’s stock grew similarly to GCTK’s over the last 12 months.
AIMD's Price Growth Rating (48) in the null industry is in the same range as GCTK (65). This means that AIMD’s stock grew similarly to GCTK’s over the last 12 months.
AIMD's P/E Growth Rating (100) in the null industry is in the same range as GCTK (100). This means that AIMD’s stock grew similarly to GCTK’s over the last 12 months.
AIMD | GCTK | |
---|---|---|
RSI ODDS (%) | N/A | N/A |
Stochastic ODDS (%) | 4 days ago84% | 4 days ago70% |
Momentum ODDS (%) | 4 days ago82% | 4 days ago90% |
MACD ODDS (%) | 4 days ago79% | 4 days ago84% |
TrendWeek ODDS (%) | 4 days ago80% | 4 days ago90% |
TrendMonth ODDS (%) | 4 days ago90% | 4 days ago70% |
Advances ODDS (%) | N/A | N/A |
Declines ODDS (%) | 4 days ago90% | 12 days ago90% |
BollingerBands ODDS (%) | 4 days ago85% | 4 days ago90% |
Aroon ODDS (%) | 5 days ago90% | 4 days ago90% |
A.I.dvisor indicates that over the last year, AIMD has been loosely correlated with AHICF. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if AIMD jumps, then AHICF could also see price increases.
Ticker / NAME | Correlation To AIMD | 1D Price Change % | ||
---|---|---|---|---|
AIMD | 100% | -2.15% | ||
AHICF - AIMD | 46% Loosely correlated | N/A | ||
BNR - AIMD | 41% Loosely correlated | +6.23% | ||
SINT - AIMD | 40% Loosely correlated | +7.64% | ||
APDN - AIMD | 38% Loosely correlated | N/A | ||
CODX - AIMD | 33% Loosely correlated | +3.08% | ||
More |
A.I.dvisor indicates that over the last year, GCTK has been closely correlated with BNR. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if GCTK jumps, then BNR could also see price increases.
Ticker / NAME | Correlation To GCTK | 1D Price Change % | ||
---|---|---|---|---|
GCTK | 100% | +0.17% | ||
BNR - GCTK | 78% Closely correlated | +6.23% | ||
SINT - GCTK | 75% Closely correlated | +7.64% | ||
APDN - GCTK | 72% Closely correlated | N/A | ||
SSKN - GCTK | 70% Closely correlated | -6.80% | ||
AIMD - GCTK | 34% Loosely correlated | -2.15% | ||
More |